Search results

...uez-Hernández MA, Navas P, Cruz R, Carracedo Á, López-Otín C, Pérez-Martos A, Fernández-Silva P, Fernández-Vizarra E, Enríquez JA (2013) Supercomplex ...uez-Hernandez MA, Navas P, Cruz R, Carracedo A, Lopez-Otin C, Perez-Martos A, Fernandez-Silva P, Fernandez-Vizarra E, Enriquez JA

..., Enríquez JA, Carracedo A, Perales JC, Nogueiras R, Herrero L, Trifunovic A, Keller MA, Yanes O, Sales-Pardo M, Guimerà R, Blüher M, Martín-Subero J ...rlos, Nogueiras Ruben, Herrero Laura, Trifunovic Aleksandra, Keller Markus A, Yanes Oscar, Sales-Pardo Marta, Guimera Roger, Blueher Matthias, Martín-S

...M, Zaliova M, Pecina P, Novak P, Houstek J, Mracek T, Kroemer G, Carracedo A, Trka J, Starkova J ...mic cells treated with ASNase but did not increase FAO. Our study uncovers a novel therapeutic option based on the combination of ASNase and FAO inhibit

...ically different. Especially, the cybrids harboring mtDNA haplogroup D had a significantly slower growth rate. These findings suggest that mitochondrial ...cals emerged as important factor for MetS as well as type 2 diabetes. With a novel cell based assays we found serum levels of mitochondria inhibitor act

...PHOS remodeling in high-grade prostate cancer involves mtDNA mutations and a prognostic gene expression signature. https://doi.org/10.26124/mitofit:1900 ...PHOS remodeling in high-grade prostate cancer involves mtDNA mutations and a prognostic gene expression signature]'''